The Battle for On-Chain Perpetual Futures: CME and CFTC Clash

The conflict between the CME Group, the largest derivatives exchange operator in the US, and its regulator, the Commodity Futures Trading Commission (CFTC), has escalated into a full-blown battle over the introduction of blockchain-based perpetual futures. The CFTC's recent approval of these products has been met with resistance from the CME, which claims that the regulator is misapplying the law and mislabeling the products. The CME argues that perpetual futures, which allow users to speculate on the price of an asset with leverage and no expiration date, are harmful to its traditional futures products and that the CFTC's decision did not consider the potential consequences. The dispute has significant implications for the US derivatives market, with the CME seeking to block the introduction of perpetual futures and the CFTC pushing forward with its plans to allow these products. The outcome of this battle will have far-reaching consequences for the development of the US derivatives market and the regulation of on-chain perpetual futures.